Patent details

Basic Information

Publication number:

EP2575784

PCT Application Number:

EP2011002764

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117273961

PCT Publication Number:

WO2011151087

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ORAL DOSAGE FORMS OF BENDAMUSTINE

French Title of Invention:

FORMES GALÉNIQUES ORALES DE BENDAMUSTINE

German Title of Invention:

ORALE DARREICHUNGSFORM VON BENDAMUSTIN

SPC Number:

Dates

Filing date:

01/06/2011

Grant date:

08/08/2018

EP Publication Date:

10/04/2013

PCT Publication Date:

08/12/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/08/2018

EP B1 Publication Date:

08/08/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

01/06/2019

Expiration date:

01/06/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/08/2018

 

 

Name:

Astellas Deutschland GmbH

Address:

Georg-Brauchle-Ring 64-66, 80992 München, Germany (DE)

Inventor

1

Name:

COLLEDGE, Jeffrey

Address:

Netherlands (NL)

2

Name:

OLTHOFF, Margaretha

Address:

Netherlands (NL)

Priority

1

Priority Number:

10075231

Priority Date:

02/06/2010

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

11075047

Priority Date:

14/03/2011

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 9/14; A61K 9/48; A61K 31/4184; A61K 47/10;

Publication

European Patent Bulletin

Issue number:

201832

Publication date:

08/08/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages